ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 46598 Null 0.000573863872925603 0.21686797
NSC 56452 Null 0.000573863872925603 0.18653902
NSC 616348 Irinotecan hydrochloride 0.000573863872925603 0.78186488
NSC 670664 Null 0.000573863872925603 0.18927486
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.000573863872925603 0.58414857
NSC 735037 Camptothecin Derivative 0.000573863872925603 0.77816086
NSC 659609 Null 0.000588249147782798 0.50732985
NSC 686362 Null 0.000588249147782798 0.36337964
NSC 726432 Null 0.000588249147782798 0.28778861
NSC 761676 Null 0.000588249147782798 0.19038538
Total:122  Current:4    [First] [Prev] [Next] [Last]